Two lots of quinapril and hydrochlorothiazide tablets have been recalled due to the presence of nitrosamines, according to a notice posted on the Food and Drug Administration’s website.
The pink, round tablets contain 20 milligrams of quinapril and 12.5 milligrams of hydrochlorothiazide and are supplied in 90-count bottles with an expiration date of January 2023. The drug is used to treat hypertension and lower blood pressure.
East Windsor, New Jersey-based Aurobindo Pharma USA Inc. shipped the recalled batches, known as QE2021005-A and QE2021010-A, to customers nationwide in May 2021.
If you or a loved one has suffered losses due to ingesting these medications, you may be entitled to compensation. To find out more, contact the trusted and experienced product liability attorneys at Breslin and Breslin today.
